You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 00:00 | 14 Aug 1348.80 -9.25
(-0.68%)
OPEN

1344.60

HIGH

1363.35

LOW

1344.55

NSE 00:00 | 14 Aug 1342.90 -2.95
(-0.22%)
OPEN

1360.00

HIGH

1360.00

LOW

1325.05

OPEN 1344.60
PREVIOUS CLOSE 1358.05
VOLUME 206
52-Week high 1949.80
52-Week low 845.15
P/E 33.69
Mkt Cap.(Rs cr) 1,148
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1344.60
CLOSE 1358.05
VOLUME 206
52-Week high 1949.80
52-Week low 845.15
P/E 33.69
Mkt Cap.(Rs cr) 1,148
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.